Annual Drug Patent Expirations for INGREZZA
Ingrezza is a drug marketed by Neurocrine and is included in one NDA. It is available from one supplier. There are nineteen patents protecting this drug.
Drug patent litigation for INGREZZA.
This drug has one hundred and thirty-four patent family members in thirty countries.
The generic ingredient in INGREZZA is valbenazine tosylate. One supplier is listed for this compound. Additional details are available on the valbenazine tosylate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
